New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PASG’s income statement to Excel — free account
Passage Bio, Inc.
PASG- EPS
- n/m
- Free cash flow
- n/m
Quarter to September 2026, against a year earlier
3.92
0.31
+8.59%
Follow PASG
Alert me
Where the cash went Twelve months to Sep 30, 2026
Free cash flow was −$32.6M: capital expenditures were more than operating cash flow. Cash fell by $32.6M. What is a cash flow statement?
- Free cash flow
- −$32.6M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- −$32.6M over the period
| Operating cash flow | −32.6 |
|---|---|
| Free cash flow | −32.6 |
| Change in cash | −32.6 |
Free cash flow
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Operating cash flow | −$32M | −$31M | −$34M | −$33M |
| Capex | $1.2M | $0.6M | $0 | $0 |
| Free cash flow | −$30M | −$30M | −$33M | −$33M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Net Income |
(33.08) | (36.11) | (37.68) | (45.52) |
+8 more TTM periods Free account |
Depreciation & Amortization |
0.33 | 0.51 | 0.66 | 0.86 | |
Non Cash Items (Other) |
2.93 | 3.23 | 5.59 | 9.16 | |
Accounts Payable Change |
(0.42) | 0.02 | 1.36 | 1.88 | |
Change in payables and accrued liability |
(0.04) | (0.51) | (0.10) | (2.05) | |
Change in other assets and liabilities |
(2.36) | (0.64) | (0.48) | 4.17 | |
Operating Cash Flow |
(32.64) | (33.50) | (30.65) | (31.51) | |
Capital expenditures |
0.02 | 0.02 | 0.61 | 1.17 | |
Short Term Investments Change (Net) |
— | — | — | 39.05 | |
Investing cash flow |
0.02 | 0.02 | 0.61 | 40.22 | |
Financing cash flow |
— | — | — | — | |
Change in Cash |
(32.61) | (33.47) | (30.02) | 8.73 | |
Beginning Cash |
46.30 | 46.30 | 46.30 | 37.57 | |
Ending Cash |
13.69 | 12.83 | 16.28 | 46.30 | |
Stock Based Compensation |
2.00 | 2.30 | 2.70 | 3.00 | |
Dividends Paid (Common) |
0.00 | 0.00 | 0.00 | 0.00 | |
Assets Liabilities Change (Total) |
(2.82) | (1.13) | 0.78 | 4.00 | |
Investments Change (Net) |
— | — | — | 39.05 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 12, 2026